Cadila Healthcare spurts on receiving final approval for Bupropion Hcl ER Tablets

21 Jan 2014 Evaluate

Cadila Healthcare is currently trading at Rs. 863.55, up by 6.10 points or 0.71 % from its previous closing of Rs. 857.45 on the BSE.

The scrip opened at Rs. 862.00 and has touched a high and low of Rs. 877.00 and Rs. 853.00 respectively. So far 11409 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 924.60 on 22-Feb-2013 and a 52 week low of Rs 631.00 on 20-Aug-2013.

Last one week high and low of the scrip stood at Rs 908.00 and Rs 849.40 respectively. The current market cap of the company is Rs 17712.79 crore.

The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 13.80% and 11.41% respectively.

Zydus Cadila has received the final approval from the United States Food and Drugs Administration (USFDA) to Bupropion Hydrochloride Extended-release Tablets USP (XL) in the strength of 300 mg. The drug falls in the anti-depressants segment. The estimated sales in 2013 as per IMS for Bupropion Hydrochloride Extended-release Tablets USP (XL), 300 mg were $255.9 million. The total market for Bupropion was estimated at $526.7 million. The group now has 87 approvals and has so far filed 216 ANDAs since the commencement of filing process in FY 2003-04.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×